Navigation Links
Strategies for Winning Clinical Investigators in a Competitive Marketplace
Date:5/1/2008

CHAPEL HILL, N.C., May 1 /PRNewswire/ -- Leading pharmaceutical companies and CROs agree that effective clinical investigator recruitment is part of the critical path in successful clinical trials and subsequent product launch. Clinical Trial Excellence: The Science and Art of Winning Investigators in a Competitive Marketplace illustrates proven techniques that speed clinical trial investigator recruitment and reduce the time to revenue.

To download a complimentary report summary, including sample best practices drawn from extensive primary research with executives at leading companies click the following or paste the link into your browser: http://www3.best-in-class.com/rr936.htm.

Companies that participated in this study are: Amersham; ALTANA Pharmaceuticals; Amgen; AAI Development; AstraZeneca; Biologicals International; Aventis; ICON; Baxter Healthcare; Parexel; Bristol-Myers Squibb; Panacos Pharmaceuticals; Eli Lilly and Company; Perlegen Sciences; GlaxoSmithKline; PPD Development; Human Genome Sciences; Janssen; PLIVA Pharmaceuticals; Pfizer; Roche; 3M Pharmaceuticals; America's Doctor; BBK Healthcare; Covance; PPD.

The report includes specific examples, more than 180 metrics, and recommendations on how to identify and close performance gaps. Additionally, this study reveals how your organization can:

-- Increase the attractiveness and credibility of studies through

effective positioning.

-- Identify key opinion leaders and investigators for protocol design

input and clinical trials.

-- Evaluate the commitment and qualifications of these investigators.

-- Create effective structures for both internal and external

accountability.

-- Partner with third parties to leverage clinical trial expertise.

To find out more about Best Practices Research and Consulting, please visit our website at http://www3.best-in-class.com/ or contact Grant Houston at 919-767-9182 or ghouston@best-in-class.com.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC is a research and consulting firm that conducts work based on the principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. For more information, call (919) 403-0251 or visit http://www3.best-in-class.com/.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Best Practice Database: Valuable Strategies for Pharmaceutical Product Launches
2. Drugs in the pipeline: new therapies that could change treatment strategies
3. Pennsylvania Health Plans Employ Various Strategies to Combat Cost of Specialty Drugs
4. Tax Planning Ideas: Sound Strategies Protect Wealth, Advises Whitnell & Co.
5. Arthur J. Gallagher & Co. Acquires Life Insurance Strategies
6. Leading Epilepsy Advocates Propose Strategies to Heighten Treatment Expectations and Close Patient and Physician Communication Gaps
7. Epilepsy advocates propose strategies to heighten treatment expectations
8. Tabula Rasa Strategies(TM), LLC, Announces Their Company Launch - A Clean Slate Approach to the Practice of Pharmaceutical Care
9. Bernard A. Krooks From the Special Needs Alliance to Talk Tax Strategies for Individuals With Disabilities Tomorrow on Good Morning America NOW
10. Adult Glioblastoma: Strategies, Challenges, and Opportunities
11. New Healthcare Study Outlines Strategies to Increase Adoption of Home Health Monitoring Technologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... ... describes the adoption of e-prescribing as measured in Part D Medicare data. The ... prescriptions to pharmacies, either using e-prescribing, faxes or paper. The PaPR (pronounced ...
(Date:4/26/2017)... ... April 26, 2017 , ... Infertility may be a result ... has helped many women become pregnant upon treating their diagnosis. , ... outpatient evaluations. We can provide the necessary information to diagnose and treat ...
(Date:4/26/2017)... LOUIS (PRWEB) , ... April 26, 2017 , ... ... designed specifically to improve the profitability of ready-to-drink, high-protein beverages by helping beverage ... economic alternative to dairy proteins, providing direct cost savings as well as more ...
(Date:4/25/2017)... ... April 25, 2017 , ... Splashtop Inc. ... Pro . This new addition to the Mirroring360 product family combines device screen ... , Mirroring360 Pro enables educators, business professionals and individuals to stream or mirror ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... HR decision-makers are preparing for how his administration could impact the employee benefits ... into what changes are most likely to make it through Congress. His discussion ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017 Global ... This report on the prostate cancer therapeutics market ... global market. Increasing prevalence of prostate cancer, launch ... in the development of new drugs & therapeutic ... cancer drug due to lesser side effects are ...
(Date:4/19/2017)... Companion animal vaccines ... pets such as canine, avian and feline. ... such as Attenuated Live Vaccines, Conjugate Vaccines, Inactivated ... Recombinant Vaccines. Attenuated live vaccines are derived from ... have been weakend under laboratory conditions. Conjugate vaccines ...
(Date:4/18/2017)... 2017  Cardinal Health (NYSE: CAH ) ... earnings per share (EPS) guidance and providing a preliminary ... conjunction with this morning,s announcement of the planned acquisition ... Insufficiency businesses. Cardinal Health now believes that ... at the bottom of its previous guidance range of ...
Breaking Medicine Technology: